ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc (RVPH)

1.34
-0.16
(-10.67%)
Closed December 22 4:00PM
1.36
0.02
(1.49%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.36
Bid
1.30
Ask
3.40
Volume
4,454,099
1.23 Day's Range 1.51
0.60 52 Week Range 5.67
Market Cap
Previous Close
1.50
Open
1.49
Last Trade Time
Financial Volume
$ 5,957,447
VWAP
1.3375
Average Volume (3m)
1,796,760
Shares Outstanding
33,441,199
Dividend Yield
-
PE Ratio
-7.45
Earnings Per Share (EPS)
-1.17
Revenue
-
Net Profit
-39.26M

About Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the dev... Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis. Show more

Sector
Blank Checks
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
2018
Reviva Pharmaceuticals Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker RVPH. The last closing price for Reviva Pharmaceuticals was $1.50. Over the last year, Reviva Pharmaceuticals shares have traded in a share price range of $ 0.60 to $ 5.67.

Reviva Pharmaceuticals currently has 33,441,199 shares outstanding. The market capitalization of Reviva Pharmaceuticals is $50.16 million. Reviva Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.45.

RVPH Latest News

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.57-53.58361774742.932.951.2579731091.75808702CS
40.118.81.254.281.0244334772.00495984CS
12-0.01-0.7299270072991.374.280.88217967601.86434001CS
26001.364.280.610867861.69334771CS
52-2.32-63.04347826093.685.670.67283622.12670198CS
156-1.64-54.666666666739.24990.536063332.93239051CS
260-8.1-85.62367864699.469.610.535640093.904752CS

RVPH - Frequently Asked Questions (FAQ)

What is the current Reviva Pharmaceuticals share price?
The current share price of Reviva Pharmaceuticals is $ 1.36
How many Reviva Pharmaceuticals shares are in issue?
Reviva Pharmaceuticals has 33,441,199 shares in issue
What is the market cap of Reviva Pharmaceuticals?
The market capitalisation of Reviva Pharmaceuticals is USD 50.16M
What is the 1 year trading range for Reviva Pharmaceuticals share price?
Reviva Pharmaceuticals has traded in the range of $ 0.60 to $ 5.67 during the past year
What is the PE ratio of Reviva Pharmaceuticals?
The price to earnings ratio of Reviva Pharmaceuticals is -7.45
What is the reporting currency for Reviva Pharmaceuticals?
Reviva Pharmaceuticals reports financial results in USD
What is the latest annual profit for Reviva Pharmaceuticals?
The latest annual profit of Reviva Pharmaceuticals is USD -39.26M
What is the registered address of Reviva Pharmaceuticals?
The registered address for Reviva Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Reviva Pharmaceuticals website address?
The website address for Reviva Pharmaceuticals is revivapharma.com
Which industry sector does Reviva Pharmaceuticals operate in?
Reviva Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

RVPH Discussion

View Posts
McMagyar McMagyar 3 days ago
Pulling defeat from absolute victory.
Absolute Trainwreck of a management team..
Sad to watch..
If you had a competent ceo .. this would have been a billion dollar market cap..
No One has confidence in the ceo other than to bank his paycheck.. 
so many people could have been helped with this drug .. by the time they get approval the patent will be gone.. maybe they will crystallize the formula and we can start all over again..
Just tough to watch.. usually the system screws these small biopharms, but Reviva over decades seems to have a talent( not unique) of finding ways do it to themselves
πŸ‘οΈ0
glenn1919 glenn1919 1 week ago
RVPH........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
RVPH.............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
RVPH...........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
RVPH...............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Paullee Paullee 2 weeks ago
crazy going on today
πŸ‘οΈ0
govprs govprs 2 weeks ago
Might be imminent big vol today
πŸ‘οΈ0
stockweiser stockweiser 3 weeks ago
OLE data in December. 
πŸ‘οΈ0
Termite7 Termite7 4 weeks ago
Any news before year end? .......Thanks!!!!
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
RVPH.......................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Termite7 Termite7 3 months ago
ETA on approval? .......Thanks!!!
πŸ‘οΈ0
Imokhopeur Imokhopeur 4 months ago
No doubt Termite
πŸ‘οΈ0
Termite7 Termite7 4 months ago
This could get to $8-or-$12 depending upon drug-approval.......


......and their pipeline is HUGE!!!!
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
RVPH.................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Imokhopeur Imokhopeur 4 months ago
It will soon make up its mind to pass 1.00 and quickly move up!!!
πŸ‘οΈ0
Triple nickle Triple nickle 4 months ago
Weeee
πŸ‘οΈ0
Imokhopeur Imokhopeur 4 months ago
Buy
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RVPH new 52=low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RVPH new 52 week low
πŸ‘οΈ0
Monroe1 Monroe1 5 months ago
Thanks!
πŸ‘οΈ0
OPennyS OPennyS 5 months ago
Because we have a long wait.

This data is crucial for their planned New Drug Application (NDA) submission to the FDA, expected in the fourth quarter of 2025.
👍️ 1
Paullee Paullee 6 months ago
https://synapse.patsnap.com/article/reviva-updates-enrollment-for-brilaroxazine-schizophrenia-study
👍️ 1
Monroe1 Monroe1 6 months ago
Why is this continuing to tank? Trial data not good?
πŸ‘οΈ0
McMagyar McMagyar 9 months ago
Well it’s below 4 not 3..
And I am praying they just sell but..
Arrogance is strong..
Also Nutriband is killing it..
Also anavex just announce the start of their schizophrenia trial..

Sell the co doc.. what lease can I say
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
RVPH under $3
πŸ‘οΈ0
McMagyar McMagyar 11 months ago
We’re just gonna wake up to a $200 sold co..
πŸ‘οΈ0
govprs govprs 11 months ago
Im back in now for the next flip opportunity
πŸ‘οΈ0
2H2 2H2 1 year ago
I closed out my shares end of day. Way outside daily bb, renter on pullback
πŸ‘οΈ0
govprs govprs 1 year ago
I would fade this. I did to be honest got a nice profit today. I believe a buyout is possible here but they need to make progress p3 trial. I’m looking to re-enter 380 -405 range. Glta
πŸ‘οΈ0
2H2 2H2 1 year ago
KRTX bought by BMY
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
I thought this was anavex!!

Haha

Revival would make sense
They have poorly managed the finances and development of this great drug for decades
Let someone else bring it to market
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
That would be a disaster for humanity
Poison pill to discourage such activity is in place
There will be no buyout
There will be no marketing partnerships

We are going straight to govts to lower their healthcare costs
πŸ‘οΈ0
2H2 2H2 1 year ago
Potential buyout here soon imo
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
Another drug which Blarcamesine could act as empowering agent
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
Because it’s a lifelong drug..
It treats symptoms safely.. but
unfortunately deoant cure the imbalance
so .. once someone is on.. they will probably never stop ..

Phase 4 confirmatory / safety would make more sense ..after nda filed and drug aold
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
23.9 improvement.

No safety issues

Get the sick the drug

The fda process sucks
πŸ‘οΈ0
govprs govprs 1 year ago
No they still have to complete another trial. It says so in the pr. If you missed the pump to 6ish then im sorry for you.
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
23.9 point improvement!
That is incredulous!

INCREDULOUS!
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
25 ? Haha..
NDA now
Use now..

πŸ‘οΈ0
govprs govprs 1 year ago
Sure they will but no nda till q1 2025. Plus this is heavily shorted.

I could be wrong and if I am atleast I made a few bucks today gltu
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
Word is they will be filing nda and become the first choice for all mental suffering humans..
Cross prescriptions for dementia..etcal..
Buy back in at $30
πŸ‘οΈ0
govprs govprs 1 year ago
Yep it was a big day with phase 3 success. Word is they will need to raise cash

I sold out with a profit and will look to get back in at some point
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
If I were not paranoid
I would wonder how a stock with 30,000,000 shares trades 43,000,000
In one day?
Can you. It a 150% of a company?
Or can you just sell 150% of a company?

What a crock..

It’s like reality has been voided
for your he stock market..

If only there was a safe and effective drug
that in four weeks could really help me
without bad side effects..
πŸ‘οΈ0
McMagyar McMagyar 1 year ago
Melt up?
πŸ‘οΈ0
govprs govprs 1 year ago
Melt down?
πŸ‘οΈ0
IPO$ IPO$ 2 years ago
This company hired Roth to raise capital. Does anyone have some insight? Curious if the FDA will approve or not
πŸ‘οΈ0
ernie44 ernie44 2 years ago
did everybody leave because it got too expensive ??????????
πŸ‘οΈ0
tootalljones tootalljones 2 years ago
you can expect a financing in the first Q of next year......they should do one now to avoid the possible recession coming next year where they now can take advantage of their stock price, less massive dilution which would come if a recession hits in Q2 which is a cointoss....cash up during the good times.
πŸ‘οΈ0
Alan Brown Alan Brown 2 years ago
No idea
πŸ‘οΈ0
govprs govprs 2 years ago
What happened?
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock